Baoshu Xie

621 citations
13 papers · 487 indexed · 1 hit paper · h-index 8
Topics
Immune Cell Function and Interaction (2 papers)RNA modifications and cancer (2 papers)Immunotherapy and Immune Responses (2 papers)
Partner nations
ChinaHong KongFrance

In The Last Decade

Baoshu Xie

11 papers receiving 485 citations

Hit Papers

Inhibition of ferroptosis attenuates tissue damage and im...20182026202020232018100200300

Peers

Baoshu Xie
Comparison fields: 5 of 72
  • Molecular Biology 327
  • Pulmonary and Respiratory Medicine 191
  • Cancer Research 188
  • Neurology 50
  • Neurology 29
Replace Xiaolong Lin with:
Xiaolong Lin China
Mingyue Zhang China
Jing Peng China
Radu Neamu United States
Mingfeng He China
Hualin Yu China
Sarah Franco United States
Baoshu Xie relative to Xiaolong Lin China Xiaolong Lin's profile →
Citations per field
00.5×3.8×
Xiaolong Lin · 1×
Citations per year

Countries citing papers authored by Baoshu Xie

Since Specialization
Citations

This map shows the geographic impact of Baoshu Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Baoshu Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Baoshu Xie more than expected).

Fields of papers citing papers by Baoshu Xie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Baoshu Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Baoshu Xie. The network helps show where Baoshu Xie may publish in the future.

Co-authorship network of co-authors of Baoshu Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Baoshu Xie. A scholar is included among the top collaborators of Baoshu Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Baoshu Xie. Baoshu Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
#WorkIndexed citations
1 0
2 0
3 18
4 16
5 1
6 1
7 17
8 16
9 53
10
Inhibition of ferroptosis attenuates tissue damage and improves long‐term outcomes after traumatic brain injury in micebreakdown →
310
11 41
12 9
13 5

About Baoshu Xie

Baoshu Xie is a scholar working on Neurology, Neurology and Immunology, having authored 13 papers that have together received 487 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (2 papers), RNA modifications and cancer (2 papers) and Immunotherapy and Immune Responses (2 papers). The work is most often cited by research in Cancer Research (188 citations), Pulmonary and Respiratory Medicine (191 citations) and Molecular Biology (327 citations). Baoshu Xie has collaborated with scholars based in China, Hong Kong and France. Frequent co-authors include Yong Lin, Junfeng Feng, Guoyi Gao, Jiyao Jiang, Qing Mao, Yiqin Wang, Jun Zhu, Jian Mao, Xin Wang and Guoqiang Hou. Their work appears in journals such as Theranostics, Journal of Neurotrauma and Redox Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026